Afya (NASDAQ:AFYA) Announces Earnings Results, Beats Expectations By $0.01 EPS

Key Points

• Afya reported a quarterly EPS of $0.39, exceeding analysts' expectations of $0.38.
• The company's stock price increased by 1.5% to $14.92 following the earnings announcement, with a market cap of $1.40 billion.
• Afya's average analyst rating is currently "Hold," with the consensus price target set at $17.50.

Afya (NASDAQ:AFYA - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.39 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.01, Zacks reports. Afya had a return on equity of 19.13% and a net margin of 19.83%. Afya updated its FY 2025 guidance to EPS.

Afya Trading Up 1.5%

Afya stock traded up $0.22 during trading hours on Wednesday, reaching $14.92. The company had a trading volume of 146,009 shares, compared to its average volume of 123,508. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.42 and a quick ratio of 1.42. The company has a 50-day moving average price of $16.21 and a 200 day moving average price of $17.24. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of 11.30, a P/E/G ratio of 0.52 and a beta of 0.53. Afya has a 12-month low of $13.47 and a 12-month high of $19.90.

Analyst Ratings Changes

AFYA has been the subject of several research analyst reports. Wall Street Zen lowered Afya from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. UBS Group reaffirmed a "neutral" rating and set a $19.50 target price (up from $17.50) on shares of Afya in a research report on Thursday, June 12th. Citigroup upgraded Afya from a "sell" rating to a "neutral" rating and cut their price target for the stock from $16.00 to $14.00 in a research note on Tuesday, July 29th. Finally, Morgan Stanley set a $17.50 price target on Afya and gave the stock an "overweight" rating in a research note on Wednesday, August 6th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Afya currently has an average rating of "Hold" and a consensus price target of $17.50.

Hedge Funds Weigh In On Afya

A number of large investors have recently bought and sold shares of the stock. Jump Financial LLC bought a new stake in shares of Afya in the 2nd quarter worth approximately $731,000. Marshall Wace LLP bought a new stake in shares of Afya in the 2nd quarter worth approximately $249,000. Arrowstreet Capital Limited Partnership grew its position in shares of Afya by 5.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company's stock worth $1,217,000 after buying an additional 3,626 shares during the last quarter. Quantbot Technologies LP bought a new stake in shares of Afya in the 2nd quarter worth approximately $117,000. Finally, Geode Capital Management LLC grew its position in shares of Afya by 85.1% in the 2nd quarter. Geode Capital Management LLC now owns 52,111 shares of the company's stock worth $931,000 after buying an additional 23,961 shares during the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.